Diabetes · Question 34 of 60
Which drug classes have been shown to also protect the heart and vessels in type 2 diabetes with heart disease?
2 answers are correct. Medium Created with AI
Show answer
Answer
- A GLP-1 receptor agonists
- B SGLT2 inhibitors
Explanation
Under the 2023 ESC guideline, people with type 2 diabetes and atherosclerotic cardiovascular disease should receive an SGLT2 inhibitor and/or a GLP-1 receptor agonist with proven cardiovascular benefit, regardless of HbA1c. No such protection has been shown for sulfonylureas.